Results 1 to 10 of about 461,681 (339)

Humanized Mouse Model as a Novel Approach in the Assessment of Human Allogeneic Responses in Organ Transplantation

Frontiers in Immunology, 2021
The outcome of organ transplantation is largely dictated by selection of a well-matched donor, which results in less chance of graft rejection. An allogeneic immune response is the main immunological barrier for successful organ transplantation.
Ashwin Ajith, Laura L. Mulloy, Md. Abu Musa, Valia Bravo-Egana, Daniel David Horuzsko, Imran Gani, Anatolij Horuzsko   +6 more
doaj   +1 more source

Regulation of Tumor Immunity by Tumor/Dendritic Cell Fusions [PDF]

, 2010
The goal of cancer vaccines is to induce antitumor immunity that ultimately will reduce tumor burden in tumor environment. Several strategies involving dendritic cells- (DCs)- based vaccine incorporating different tumor-associated antigens to induce ...
Gong, Jianlin, Hara, Eiichi, Homma, Sadamu, Ito, Masaki, Koido, Shigeo, Komita, Hideo, Nagasaki, Eijiro, Namiki, Yoshihisa, Ohkusa, Toshifumi, Tajiri, Hisao, Takahara, Akitaka   +10 more
core   +16 more sources

A 4-year follow-up study of 20 cases of stable localized childhood vitiligo treated by autologous, noncultured melanocyte–keratinocyte cell transplantation

Pigment International, 2023
Background: Vitiligo is a common skin disease affecting 1% to 2% of general population. Even though different modalities of treatment available, it remains as a difficult disease to treat.
Ettappurath N Abdul Latheef, S. Rahima, K. Muhammed, Najeeba Riyaz   +3 more
doaj   +1 more source

Type 2 diabetes mellitus duration and obesity alter the efficacy of autologously transplanted bone marrow‐derived mesenchymal stem/stromal cells

Stem Cells Translational Medicine, 2021
Human bone marrow‐derived mesenchymal stem/stromal cells (BM‐MSCs) represent promising stem cell therapy for the treatment of type 2 diabetes mellitus (T2DM), but the results of autologous BM‐MSC administration in T2DM patients are contradictory.
Liem Thanh Nguyen, Duc M. Hoang, Kien T. Nguyen, Duc M. Bui, Hieu T. Nguyen, Hong T.A. Le, Van T. Hoang, Hue T. H. Bui, Phuong T.M. Dam, Xuan T.A. Hoang, Anh T.L. Ngo, Hang M. Le, Nhi Y. Phung, Duc M. Vu, Trung T. Duong, Tu D. Nguyen, Lien T. Ha, Hoa T.P. Bui, Hoa K. Nguyen, Michael Heke, Anh V. Bui   +20 more
doaj   +1 more source

Single arm unicentric study to evaluate the efficacy of autologous noncultured nontrypsinized epidermal cell grafting (Jodhpur technique) in stable acral vitiligo

Journal of Dermatology and Dermatologic Surgery, 2023
Background: Autologous noncultured, nontrypsinized melanocyte–keratinocyte grafting (Jodhpur technique [JT]) is an unconventional innovative surgical modality for the treatment of stable vitiligo.
Deepak Sharma, Paras Choudhary, Rahul Singrodia, Manju L Verma, Pankaj Rao, Dilip Kachhawa   +5 more
doaj   +1 more source

Immediate autotransplantation of a mandibular premolar with complete roots to a fractured tooth site, using platelet-rich fibrin in an orthodontic patient, report of a case

Dental Research Journal, 2023
Transplantation of one tooth to another site in the same individual can be considered an attractive alternative to dental implants or fixed prostheses.
Sara Alijani, Ali Ghamari, Azadeh Kazemi Saleh, Maryam Salehzadeh   +3 more
doaj   +1 more source

Autologous non-cultured keratinocyte cell suspension in non-healing diabetic ulcers: A preliminary study

Journal of Family Medicine and Primary Care, 2020
Background: Diabetic ulcers are a common morbidity associated with poorly controlled glycemic status. Most patients often have neuropathy and vasculopathy as the etiology behind such ulcers.
Shruti Barnwal, Ravi Kant, Poonam Yadav
doaj   +1 more source

A survey on cellular and engineered tissue therapies in Europe in 2008 [PDF]

, 2010
Cellular therapy is an evolving investigational treatment modality in regenerative medicine, but little published information is available on its current use.
Baldomero, Helen, Gratwohl, Alois, Martin, Ivan, Niederwieser, Dietger, Tyndall, Alan   +4 more
core   +1 more source

Immunological Response Against SARS-COV-2 After BNT162b2 Vaccine Administration Is Impaired in Allogeneic but Not in Autologous Stem Cell Transplant Recipients

Frontiers in Oncology, 2021
The efficacy of Covid-19 vaccine in hematopoietic stem cell transplantation (HSCT) recipients is still unknown. We planned a prospective study to evaluate the immune response after the administration of Covid-19 vaccine in HSCT recipients. Fifty patients
Martina Chiarucci, Sara Paolasini, Alessandro Isidori, Barbara Guiducci, Federica Loscocco, Maria Capalbo, Giuseppe Visani   +6 more
doaj   +1 more source

High dose melphalan is an adequate preparative regimen for autologous hematopoietic stem cell transplantation in relapsed/refractory lymphoma

Hematology, 2022
Introduction High-dose melphalan (HD-Mel) has been successfully employed in autografting patients with multiple myeloma. An advantage of this regimen is that the total dose of Mel can be delivered in a single day, being particularly useful when non ...
José A. Fernández-Gutiérrez, Oscar A. Reyes-Cisneros, Mark R. Litzow, Lorena Bojalil-Álvarez, Elizabeth García-Villaseñor, Eliezer Tomas Gómez-Gomez, Iván Murrieta-Álvarez, David Gomez-Almaguer, Cesar H. Gutierrez-Aguirre, Amado J. Karduss-Urueta, Guillermo J. Ruiz-Delgado, Guillermo José Ruiz-Argüelles   +11 more
doaj   +1 more source